Esophageal Cancer Responsive to Immune Cell Therapy + Nivolumab Esophageal Cancer Responsive to Immune Cell Therapy + Nivolumab

This report suggests that a combination of adoptive immune cell therapy and an immune checkpoint inhibitor might be a possible treatment strategy for advanced esophageal cancer.Journal of Medical Case Reports
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news